BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  OctoPlus Announces 2011 First Half-Year Results

  July 29, 2011

   · 

  5 min read
• Business

  NuVasive, Inc. Announces Appointment of Peter Leddy, Ph.D., to the NuVasive Board of Directors

  July 29, 2011

   · 

  4 min read
• Business

  Osiris Therapeutics, Inc. Announces Second Quarter 2011 Financial Results Conference Call

  July 29, 2011

   · 

  1 min read
• Drug Development

  ISTA Pharmaceuticals, Inc. Reports Results From the First of Two Trials in the REMURA(TM) Phase 3 Clinical Program for Dry Eye Disease

  July 29, 2011

   · 

  7 min read
• Business

  Uroplasty, Inc. Reports Financial Results for the First Quarter of Fiscal 2012

  July 29, 2011

   · 

  6 min read
• Drug Development

  BioMarin Pharmaceutical Inc. Provides Update on GALNS Phase 1/2 Extension Study (MOR-100)

  July 29, 2011

   · 

  4 min read
• Business

  DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call

  July 29, 2011

   · 

  1 min read
• Pharm Country

  Roka Bioscience, Inc. Pulls in $20 Million

  July 29, 2011

   · 

  2 min read
• Pharm Country

  Applied DNA Sciences, Inc. to Host Investor Conference Call Thursday, August 11, 2011

  July 29, 2011

   · 

  3 min read
• ALR Technologies Inc. Release: Clinical Trial Follow-up Confirms Discontinuation of Intensive Blood Glucose Control Results in Reversal of A1c Improvement

  July 29, 2011

   · 

  3 min read